What are the treatment options for upper respiratory tract infections (URTI) and sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Upper Respiratory Tract Infections and Sinusitis

Distinguishing Viral from Bacterial Sinusitis: The Critical First Step

Most URTIs (98-99.5%) are viral and resolve spontaneously within 7-10 days without antibiotics—only prescribe antibiotics when bacterial sinusitis is confirmed by specific clinical criteria. 1

Diagnose acute bacterial sinusitis only when one of three patterns is present:

  • Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, or cough) 2, 1
  • Severe symptoms for ≥3 consecutive days: fever ≥39°C with purulent nasal discharge and facial pain 2, 1
  • "Double sickening": worsening symptoms after initial improvement from a viral URI 2, 1

First-Line Antibiotic Treatment for Acute Bacterial Sinusitis

Adults

Amoxicillin remains the first-line antibiotic for uncomplicated acute bacterial sinusitis in adults. 2, 1

  • Standard dosing: 500 mg twice daily for mild disease 1
  • High-dose: 875 mg twice daily for moderate disease or areas with high S. pneumoniae resistance 2, 1
  • Duration: 10-14 days or until symptom-free for 7 days 2, 1

For patients with recent antibiotic exposure or risk factors, start with high-dose amoxicillin-clavulanate 875/125 mg twice daily. 1 This provides coverage against β-lactamase-producing H. influenzae and M. catarrhalis, which have become increasingly prevalent. 1

Pediatric Patients (≥3 months)

  • Standard-dose amoxicillin: 45 mg/kg/day divided into 2 doses 1
  • High-dose amoxicillin: 80-90 mg/kg/day divided into 2 doses for children <2 years, daycare attendance, recent antibiotic use, or high local resistance 1
  • High-dose amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses for children with risk factors 2, 1

Penicillin-Allergic Patients

For non-severe penicillin allergy (rash, mild reactions), second- or third-generation cephalosporins are safe and effective first-line alternatives. 1 The risk of cross-reactivity is negligible. 1

Preferred options:

  • Cefuroxime-axetil (second-generation cephalosporin) 2, 1
  • Cefpodoxime-proxetil (third-generation, superior H. influenzae coverage) 2, 1
  • Cefdinir (third-generation, excellent coverage) 2, 1

For documented severe Type I hypersensitivity (anaphylaxis), use respiratory fluoroquinolones: levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily for 10-14 days. 1

Critical Pitfall to Avoid

Never use azithromycin or other macrolides as first-line therapy—resistance rates exceed 20-25% for both S. pneumoniae and H. influenzae. 1, 3 French and American guidelines explicitly exclude macrolides from recommended therapy due to resistance prevalence. 1

Treatment Failure Protocol

Reassess patients at 3-5 days (adults) or 72 hours (pediatrics)—if no improvement, switch antibiotics immediately. 2, 1

Second-Line Options After Amoxicillin Failure

Switch to high-dose amoxicillin-clavulanate 875/125 mg twice daily (adults) or 90 mg/kg/day amoxicillin component (pediatrics). 2, 1 This covers β-lactamase-producing organisms and drug-resistant S. pneumoniae. 1

If amoxicillin-clavulanate fails or patient has severe penicillin allergy, use respiratory fluoroquinolones: levofloxacin 500-750 mg once daily or moxifloxacin 400 mg once daily for 10 days. 1 These provide 90-92% predicted clinical efficacy against multi-drug resistant organisms. 1

Alternative for Treatment Failures

Ceftriaxone 1-2 g IM/IV once daily for 5 days (adults) or 50 mg/kg once daily (pediatrics) is indicated when oral antibiotics fail or patient cannot tolerate oral medications. 1 This achieves 90-92% clinical efficacy with once-daily dosing that improves compliance. 1

Sinusitis by Anatomic Location

Maxillary Sinusitis (Most Common)

Use standard first-line antibiotics as outlined above. 2, 1 Symptoms include unilateral/bilateral infraorbital pain worsening when bending forward, pulsatile, peaking evening/night. 1

Frontal, Ethmoidal, or Sphenoidal Sinusitis

Reserve fluoroquinolones (levofloxacin 500 mg or moxifloxacin 400 mg once daily) for these locations due to potential for serious complications. 2, 1 These sites require more aggressive therapy and may necessitate hospitalization for parenteral antibiotics. 2

Adjunctive Therapies

Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily) should be used as adjunct to antibiotic therapy—they reduce mucosal inflammation and improve symptom resolution. 2, 1 Strong evidence from multiple RCTs supports this recommendation. 1

Short-term oral corticosteroids (typically 5 days) are reasonable for patients who fail initial treatment, have nasal polyposis, or demonstrate marked mucosal edema. 2, 1 However, never give systemic corticosteroids without antibiotics when bacterial sinusitis is suspected, as this may suppress immune response and allow bacterial proliferation. 1

Symptomatic Measures

  • Adequate hydration and rest 2
  • Analgesics (acetaminophen, NSAIDs) for pain 2, 1
  • Warm facial packs 2
  • Saline nasal irrigation for symptomatic relief 1
  • Sleeping with head elevated 2
  • Decongestants (systemic or topical) as needed 1

Special Considerations and When to Refer

Refer to otolaryngology or allergist-immunologist when:

  • Symptoms refractory to two courses of appropriate antibiotics 1
  • Recurrent sinusitis (≥3 episodes per year) 2, 1
  • Suspected complications (orbital cellulitis, meningitis) 1
  • Need for sinus aspiration/culture in immunocompromised patients 1
  • Evaluation for underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities 2, 1

Critical Pitfalls to Avoid

Do not prescribe antibiotics for viral rhinosinusitis lasting <10 days—this contributes to antimicrobial resistance without clinical benefit. 1 Wait at least 10 days before considering antibiotics unless severe symptoms are present. 1

Do not use mucus color alone to determine antibiotic need—purulent discharge reflects neutrophils, not necessarily bacteria. 1

Ensure adequate treatment duration (minimum 5-10 days, typically 10-14 days) to prevent relapse. 2, 1 Some cephalosporins are effective in 5-day courses, but standard therapy remains 7-10 days. 2, 1

Reserve fluoroquinolones for treatment failures, complicated sinusitis, or severe penicillin allergy—overuse promotes resistance. 2, 1

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.